A Plant-Based Strategy for MASLD: Desmodium caudatum (Thunb.) DC. Extract Reduces Hepatic Lipid Accumulation and Improves Glycogen Storage In Vitro and In Vivo
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178442 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yu-Ching Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Antai Medical Care Corporation Antai Tian-Sheng Memorial Hospital, Pingtung 928, Taiwan. Hauptthemen laut MEDLINE: Plant Extracts, Lipid Metabolism, Liver, Glycogen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Antai Medical Care Corporation, Antai Tian-Sheng Memorial Hospital, Pingtung County, Taiwan.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by hepatic lipid accumulation and insulin resistance, yet effective therapies remain limited. This study evaluated the hepatoprotective effects of Desmodium caudatum (Thunb.) DC. Extract (DCE) in vitro and in vivo. In 600 μM oleic acid (OA)-challenged HepG2 cells, DCE (25, 50, and 100 μg/mL) reduced lipid accumulation, oxidative stress, and glycogen depletion by modulating lipogenic and oxidative pathways. In a MASLD mouse model induced by high-fat diet (HFD)/streptozotocin (HFD/STZ), oral administration of DCE (100 or 200 mg/kg) for six weeks improved fasting glucose, serum lipids, and hepatic injury markers. Histology confirmed reduced steatosis, while Western blotting showed downregulation of SREBP-1, HMGCR, and ACC, and upregulation of CPT-1, PPARα, and phosphorylated AMPK. Additionally, DCE enhanced insulin signaling and restored hepatic glycogen synthesis through IRS-1, AKT, and GSK3β activation. These findings suggest that DCE ameliorates MASLD by regulating lipid and glucose metabolism, supporting its potential as a plant-based therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Antai Medical Care Corporation Antai Tian-Sheng Memorial Hospital, Pingtung 928, Taiwan.
- Department of Nutrition, Chung Shan Medical University, Taichung City 402, Taiwan.
- Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung City 402, Taiwan.
- Department of Medical Research, Chung Shan Medical University Hospital, Taichung City 402, Taiwan.
ORCID-Profile: Hui-Hsuan Lin, Jing-Hsien Chen
Förderung
- Antai Medical Care Corporation, Antai Tian-Sheng Memorial Hospital, Pingtung County, Taiwan
Zitieren
APA
Chen, Y. C., Liang, Y. H., Wong, Y., Tseng, C. Y., Chang, C. W., Lin, H. H., & Chen, J. H. (2025). A Plant-Based Strategy for MASLD: Desmodium caudatum (Thunb.) DC. Extract Reduces Hepatic Lipid Accumulation and Improves Glycogen Storage In Vitro and In Vivo. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178442
Vancouver
Chen YC, Liang YH, Wong Y, Tseng CY, Chang CW, Lin HH, et al. A Plant-Based Strategy for MASLD: Desmodium caudatum (Thunb.) DC. Extract Reduces Hepatic Lipid Accumulation and Improves Glycogen Storage In Vitro and In Vivo. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178442
BibTeX
@article{Chen2025,
author = {Chen, Yu-Ching and Liang, Yu-Hsuan and Wong, Yueching and Tseng, Chiao-Yun and Chang, Chi-Wen and Lin, Hui-Hsuan and Chen, Jing-Hsien},
title = {A Plant-Based Strategy for MASLD: Desmodium caudatum (Thunb.) DC. Extract Reduces Hepatic Lipid Accumulation and Improves Glycogen Storage In Vitro and In Vivo},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178442}
}
EUVIMED